
Claritas Pharmaceuticals, Inc. — Investor Relations & Filings
Claritas Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of therapeutic products addressing areas of unmet medical need. The company maintains a portfolio of pharmaceutical candidates, with a primary focus on advancing its lead compound, R-107. R-107 is being developed as a potential therapy for various viral infections, including influenza and COVID-19. The company's development pipeline also explores treatments within therapeutic areas such as Nervous System Diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material change report - English.pdf | 2022-07-22 | English | |
| News release - English.pdf | 2022-07-22 | English | |
| News release - English.pdf | 2022-06-24 | English | |
| Material change report - English.pdf | 2022-05-16 | English | |
| News release - English.pdf | 2022-05-13 | English | |
| News release - English.pdf | 2022-05-05 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 14324577 | Material change report - English.pdf | 2022-07-22 | English | ||
| 14324579 | News release - English.pdf | 2022-07-22 | English | ||
| 24970611 | News release - English.pdf | 2022-06-24 | English | ||
| 13591523 | Material change report - English.pdf | 2022-05-16 | English | ||
| 13589236 | News release - English.pdf | 2022-05-13 | English | ||
| 24505515 | News release - English.pdf | 2022-05-05 | English | ||
| 24732939 | News release - English.pdf | 2022-04-30 | English | ||
| 13581829 | Material change report - English.pdf | 2022-04-15 | English | ||
| 13581093 | News release - English.pdf | 2022-04-07 | English | ||
| 13578637 | News release - English.pdf | 2022-04-06 | English | ||
| 23974263 | News release - English.pdf | 2022-04-05 | English | ||
| 13578145 | News release - English.pdf | 2022-04-04 | English | ||
| 13558396 | News release - English.pdf | 2022-01-27 | English | ||
| 13557299 | News release - English.pdf | 2022-01-17 | English | ||
| 13557321 | News release - English.pdf | 2022-01-17 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Claritas Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45562/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45562 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45562 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45562 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45562}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Claritas Pharmaceuticals, Inc. (id: 45562)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.